The Leukemia and Lymphoma Society announced the launch of the Beat AML Master Trial, in which several medical centers and biopharmaceutical companies will collaboratively test multiple experimental drugs in patients with the disease who are over age 60 and whose cancer has one of nine genomic signatures.
http://ift.tt/2gX2QUv
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου